Search

Achal S Achrol

from Highland, CA
Age ~44
Get Report
Also known as:
Achal Singh Achrol, Achal K Achrol, Achal K Singh, Acna S Achro, Achrol Achal, L L
Related to:
Brij Raj Singh, 69Baljeet Kaur, 52Rajinder Singh, 67Ripam Singh, 42
Connected to:
Elaine M Achs, 61Shawn R Achtel, 42Dagmar M Achtelik, 65Thomas M Achtemichuk, 45Randy J Achten, 75Abbi L Achterberg, 44Adam J Achter, 36Angel Achterbosch, 53Anita T Achterberg, 95Constance Achterberg, 94

Achal Achrol Phones & Addresses

  • Highland, CA
  • Alhambra, CA
  • 952 Via Del Monte, Pls Vrds Pnsl, CA 90274 (650) 796-6349
  • Palos Verdes Estates, CA
  • Malibu, CA
  • 2030 Valparaiso Ave, Menlo Park, CA 94025
  • Palo Alto, CA
  • San Francisco, CA
  • Vienna, VA
  • Pala, CA
  • Reston, VA
  • McLean, VA

Work

Company: Stanford Med Ctr Neurosurgery Address: 300 Pasteur Dr, Stanford, CA 94305

Education

School / High School: Stanford University 2009

Professional Records

Medicine Doctors

Achal Achrol Photo 1

Dr. Achal S Achrol - MD (Doctor of Medicine)

View page
Hospitals:
Stanford Med Ctr Neurosurgery
300 Pasteur Dr, Stanford, CA 94305
Education:
Medical Schools
Stanford University
Graduated: 2009
Achal Achrol Photo 2

Achal S. Achrol

View page
Specialties:
Surgery , Neurological
Work:
John Wayne Cancer Institute
2121 Santa Monica Blvd Gdn Lvl, Santa Monica, CA 90404
(310) 315-6125 (phone), (310) 582-7495 (fax)
Education:
Medical School
Stanford University
Graduated: 2009
Languages:
English
Description:
Dr. Achrol is Chief of Glioma Surgery at John Wayne Cancer Institute and Director of Neurovascular Surgery and Neurocritical Care at Pacific Neuroscience Institute at Providence Saint Johns Health Center in Santa Monica (Los Angeles), California. Dr. Achrol specializes in minimally-invasive neurosurgery and advanced clinical trials, including stem cell therapies, cancer vaccines, and

Publications

Us Patents

Microfluidic System And Method For Automated Processing Of Particles From Biological Fluid

View page
US Patent:
20120270331, Oct 25, 2012
Filed:
Apr 20, 2012
Appl. No.:
13/452760
Inventors:
Achal Singh Achrol - Menlo Park CA, US
Palaniappan Sethu - Louisville KY, US
Richard S. Gaster - Mountain View CA, US
International Classification:
G01N 1/18
B01L 3/00
US Classification:
436177, 422502
Abstract:
A microfluidic system for automatically depleting particles not of interest from a biological sample, comprising: a sampling module configured to receive the sample; and one or more microfluidic protein and nucleic acid depletion modules fluidically coupled to the sampling module and comprising binding agents configured to selectively bind to abundant plasma proteins or nucleic acids. A method for automatically depleting particles not of interest from a sample, comprising: receiving the sample; subjecting the sample to a force that separates at least a portion of the particles not of interest from the sample, thereby isolating at least a portion of the target component; passing the isolated target copmonent into a chamber; circulating the isolated target component in the chamber; and selectively capturing proteins or nucleic acids with binding agents within the chamber.

Microfluidic Method And System For Isolating Particles From Biological Fluid

View page
US Patent:
20110020459, Jan 27, 2011
Filed:
May 13, 2010
Appl. No.:
12/779746
Inventors:
Achal Singh Achrol - Menlo Park CA, US
Palaniappan Sethu - Louisville KY, US
International Classification:
A61K 35/12
G01N 33/53
C12M 1/34
US Classification:
424520, 435 721, 4352871
Abstract:
The invention relates to a system and method for isolating particles from a biological fluid, including: obtaining a sample of biological fluid from a source (e.g. a patient) in which the sample contains particles of multiple sample particle types; tagging particles in the sample with tagging agents, including mixing the sample with a solution of magnetic tagging agents that selectively bind to particles of at least one of the sample particle types, thereby forming a group of tagged particles in the sample; passing the sample through a magnetic conduit having a magnetic field that interacts with at least some of the tagged particles; sorting the particles of the sample into multiple groups based on the interaction between the tagged particles and the magnetic field; and optionally returning selected portions of the processed fluid back to its source with or without the addition of appropriate therapeutic agents.

Intracranial Diagnostics Using Optical Imaging Of Coherent Light Interference

View page
US Patent:
20230029744, Feb 2, 2023
Filed:
Jul 28, 2021
Appl. No.:
17/387279
Inventors:
- San Francisco CA, US
Brad Hartl - San Mateo CA, US
Kedar Grama - Sausalito CA, US
Achal Singh Achrol - Highland CA, US
International Classification:
A61B 5/00
G06T 7/00
G06T 7/20
G06K 9/20
G08B 7/06
A61B 5/026
Abstract:
Coherent light (e.g., laser light) is emitted into a cranium through an optical fiber. A tissue sample (e.g., red blood cells, blood vessels, brain tissue) within the cranium diffuses the coherent light. Different tissue sample motion quantities generate different coherent light interference patterns. An image of a coherent light interference pattern is captured with an image sensor coupled to an optical element. The speckle contrast of the image quantifies coherent light interference pattern. A waveform of sequentially captured speckle contrast values over time has characteristics that reflect intracranial blood flow health. If waveform characteristics indicate poor or questionable intracranial blood flow heath, a notification message is displayed, played, or otherwise transmitted.
Control profile
Achal S Achrol from Highland, CA, age ~44 Get Report